Effect of Lavender on Sleep Quality and Insomnia Severity in Patients

September 13, 2025 updated by: bülent devrim akçay, Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Effect of Lavender on Sleep Quality and Insomnia Severity in Patients With Psychophysiological Insomnia

Today, psychophysiological insomnia is the most common persistent insomnia. Lavender essential oil is frequently used in the literature as an aromatherapy method to improve sleep quality. Studies have found that lavender improves sleep quality. They also emphasized that more studies are needed in this area. When the relevant literature is reviewed, no studies examining the effects of lavender oil on patients with psychophysiological insomnia were found. In this context, the aim of the study was to evaluate the effect of lavender on sleep quality and insomnia severity in patients with psychophysiological insomnia.

Study Overview

Detailed Description

Today, psychophysiological insomnia is the most common persistent insomnia. The patient's inability to sleep occurs as a result of repetitive negative thoughts such as the thought that he will have difficulty sleeping before going to bed and/or past experiences involving the bedroom or the night. More effort to sleep causes more wakefulness and more difficulty falling asleep.

Numerous studies have shown that insomnia seriously affects health and quality of life and can cause various problems including memory problems, depression, irritability, cardiovascular and cerebrovascular diseases, etc. Therefore, looking for effective ways to improve sleep quality is important for individual and social health. Today, drug therapy, psychotherapy, physiotherapy and cognitive-behavioral therapy are widely used treatments for insomnia. Recently, more and more studies have found that aromatherapy is one of the non-drug treatments to improve sleep quality. Lavender essential oil appears in the literature as an aromatherapy method frequently used to improve sleep quality.

Studies have found that lavender improves sleep quality. They also emphasized that more studies are needed in this area. When the relevant literature was examined, no studies were found examining the effects of lavender oil on patients with psychophysiological insomnia. In this context, the aim of the study was to evaluate the effect of lavender on sleep quality and insomnia severity in patients with psychophysiological insomnia.

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Keçiören
      • Ankara, Keçiören, Turkey (Türkiye), 06010
        • University of Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being 18 years of age or older,
  • Being over 65 years old
  • Being diagnosed with psychophysiological insomnia,
  • Knowing Turkish at a level that will allow you to read and understand the survey questions,
  • Accepting to participate in the study

Exclusion Criteria:

  • Having a serious physical or cognitive disability that would prevent him/her from answering the survey,
  • Being under the age of 18,
  • Not accepting to participate in the study,
  • Being allergic to lavender,
  • Having a chronic additional disease related to the respiratory system,
  • Having a psychiatric or neurological additional disease,
  • Using medication(s) that may affect sleep,
  • Experiencing a physical activity limitation that causes bedriddenness,
  • Having or contracting a disease that will affect the ability to smell.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: lavender sachet group
The normal procedure applied in the sleep clinic (keeping a sleep diary, sleep hygiene education) will be followed and participants will be asked to sleep with lavender sachets inside their pillows for two weeks.
The normal procedure applied in the sleep clinic (keeping a sleep diary, sleep hygiene education) will be followed and participants will be asked to sleep with lavender sachets inside their pillows for two weeks.
Sham Comparator: Control group
Participants will follow the normal procedure applied (keeping a sleep diary, sleep hygiene training) in the sleep clinic and no additional intervention will be performed.
Participants will follow the normal procedure applied (keeping a sleep diary, sleep hygiene training) in the sleep clinic and no additional intervention will be performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Pittsburgh Sleep Quality Index
Time Frame: two weeks
PSQI is a 19-item scale, assessed by self-report (19 items) and spouse/roommate responses (5 items). The scale includes components such as sleep quality, duration, and disturbance, and the total score ranges from 0 to 21; a score greater than 5 indicates poor sleep quality.
two weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Insomnia Severity Index
Time Frame: two weeks
ISS is a 7-item self-report scale. The total score obtained from this scale varies between 0 and 28, and a score of 15 and above indicates clinical insomnia.
two weeks
The Epworth Sleepiness Scale
Time Frame: two weeks
ESS is a four-point Likert-type scale consisting of 8 items. The score range of this scale is 0 to 24, and a score of 10 and above indicates excessive daytime sleepiness.
two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bülent D. Akçay, Assoc. Prof., Saglik Bilimleri Universitesi
  • Principal Investigator: Mehmet Koçer, MD, Gulhane Training and Research Hospital
  • Principal Investigator: Duygu Akçay, Asst.Prof, Ufuk University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 21, 2025

Primary Completion (Actual)

July 21, 2025

Study Completion (Actual)

September 12, 2025

Study Registration Dates

First Submitted

January 12, 2025

First Submitted That Met QC Criteria

January 12, 2025

First Posted (Actual)

January 16, 2025

Study Record Updates

Last Update Posted (Estimated)

September 16, 2025

Last Update Submitted That Met QC Criteria

September 13, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insomnia, Psychophysiological

Clinical Trials on lavender sachet group

Subscribe